Vita Life Sciences (ASX:VLS) Cash Flow for Dividends: A$-6.08 Mil (TTM As of Dec. 2025)


ASX:VLS Vita Life Sciences Ltd ASX:VLS
94 GF Score
Price A$2.50
GF Value A$2.47
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Vita Life Sciences Cash Flow for Dividends?

Vita Life Sciences ASX:VLS 94 Cash Flow for Dividends is A$-6.08 Mil as of Dec. 2025. GuruFocus rates ASX:VLS with a GF Score™ of 94/100 and a GF Value™ of A$2.47 (Fairly Valued). The stock has 1 warning sign investors should review.

Vita Life Sciences's cash flow for dividends for the six months ended in Dec. 2025 was A$-2.47 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was A$-6.08 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Vita Life Sciences's quarterly payment of dividends increased from Dec. 2024 (A$-1.91 Mil) to Jun. 2025 (A$-3.61 Mil) but then declined from Jun. 2025 (A$-3.61 Mil) to Dec. 2025 (A$-2.47 Mil).

Vita Life Sciences's annual payment of dividends increased from Dec. 2023 (A$-3.37 Mil) to Dec. 2024 (A$-5.17 Mil) and increased from Dec. 2024 (A$-5.17 Mil) to Dec. 2025 (A$-6.08 Mil).

Vita Life Sciences Cash Flow for Dividends Related Terms

Vita Life Sciences Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Vita Life Sciences's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vita Life Sciences Cash Flow for Dividends Chart

Vita Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.90 -3.04 -3.37 -5.17 -6.08

Vita Life Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 -3.26 -1.91 -3.61 -2.47
ASX:VLS
94GF Score
Vita Life Sciences Ltd ASX:VLS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vita Life Sciences Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-6.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of A$-6.08 Mil mean?
Vita Life Sciences (ASX:VLS) has a Cash Flow for Dividends of A$-6.08 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Vita Life Sciences and its competitors.
Is Vita Life Sciences' Cash Flow for Dividends too high?
Vita Life Sciences' current Cash Flow for Dividends is A$-6.08 Mil. Overall, Vita Life Sciences has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vita Life Sciences' Cash Flow for Dividends compare to ZTS?
Vita Life Sciences' Cash Flow for Dividends of A$-6.08 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Vita Life Sciences and its competitors. Vita Life Sciences's current Cash Flow for Dividends is A$-6.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vita Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.47, compared to a current price of A$2.50 — trading 1.2% above its estimated fair value. The current Cash Flow for Dividends is A$-6.08 Mil. Vita Life Sciences' overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current Cash Flow for Dividends is A$-6.08 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?

Based on GuruFocus' analysis, Vita Life Sciences stock appears to be overvalued. The current stock price of A$2.50 is trading 1.2% above its estimated GF Value™ of A$2.47. GuruFocus considers Vita Life Sciences to be Fairly Valued.

Key valuation signals for ASX:VLS:

  • Cash Flow for Dividends: A$-6.08 Mil
  • GF Value™: A$2.47 vs. price of A$2.50 (1.2% above fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vita Life Sciences Business Description

Address 1-5 Chalmers Crescent, Suite 802, Level 8, Mascot, Sydney, NSW, AUS, 2020
Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.
94GF Score

Get the complete analysis for ASX:VLS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.50
Price
A$2.47
GF Value